GB1432784A - Orally administrable pharmaceutical compositions - Google Patents
Orally administrable pharmaceutical compositionsInfo
- Publication number
- GB1432784A GB1432784A GB5273473A GB5273473A GB1432784A GB 1432784 A GB1432784 A GB 1432784A GB 5273473 A GB5273473 A GB 5273473A GB 5273473 A GB5273473 A GB 5273473A GB 1432784 A GB1432784 A GB 1432784A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compositions
- orally administrable
- nov
- administrable pharmaceutical
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1432784 Orally administrable medicines SUMITOMO CHEMICAL CO LTD 13 Nov 1973 [18 Nov 1972] 52734/73 Heading A5B Pharmaceutical compositions for oral administration having enhanced resorbability of the drug comprise a drug dissolved or suspended in a liquid mono-glyceride of a C6-12 fatty acid or a mixture of such glycerides. Various drugs are mentioned including chloramphenicol, grisiofulrin, phenobarbitol, aspirin, sulpha drugs, indomethacin, diazepam, pentazocine and 1-cyclopropylmethyl-4-phenyl-6- chloro-2(1H) quinazolinone.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11602172A JPS4971127A (en) | 1972-11-18 | 1972-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1432784A true GB1432784A (en) | 1976-04-22 |
Family
ID=14676810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5273473A Expired GB1432784A (en) | 1972-11-18 | 1973-11-13 | Orally administrable pharmaceutical compositions |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS4971127A (en) |
BE (1) | BE807312A (en) |
CA (1) | CA1036072A (en) |
DE (1) | DE2357389A1 (en) |
FR (1) | FR2206943B1 (en) |
GB (1) | GB1432784A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4202888A (en) * | 1976-07-12 | 1980-05-13 | Kali-Chemie Pharma Gmbh. | Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof |
US4230702A (en) * | 1978-01-09 | 1980-10-28 | Kali-Chemie Pharma Gmbh | Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents |
US4263313A (en) | 1977-02-24 | 1981-04-21 | Kali-Chemie Pharma Gmbh | Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof |
US4722941A (en) * | 1978-06-07 | 1988-02-02 | Kali-Chemie Pharma Gmbh | Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof |
US5156842A (en) * | 1987-06-19 | 1992-10-20 | Elan Corporation, Plc | Liquid suspension for oral administration |
US7943663B2 (en) | 2005-09-30 | 2011-05-17 | Suntory Holdings Limited | Process and an apparatus for producing episesamin-rich compositions |
US9408803B2 (en) | 2006-03-31 | 2016-08-09 | Suntory Holdings Limited | Compositions containing lignan-class compounds |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4167558A (en) | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
AT358530B (en) * | 1978-04-25 | 1980-09-10 | Plc Pharma Licences | STABILIZATION PROCEDURE |
FR2427100A1 (en) * | 1978-06-02 | 1979-12-28 | Kali Chemie Pharma Gmbh | Highly soluble and stable basic pharmaceuticals in glyceride mixt. - are prepd. by converting to fatty acid salts by addn. of free fatty acid |
FR2500302B1 (en) * | 1981-02-25 | 1985-11-15 | Negma Laboratoires | NEW PHARMACEUTICAL COMPOSITIONS OF INDOMETACIN |
JPS5877810A (en) * | 1981-11-01 | 1983-05-11 | Taiho Yakuhin Kogyo Kk | Oral drug composition containing polyglycerol unsaturated fatty acid ester |
US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
JPS60153758A (en) * | 1984-01-23 | 1985-08-13 | Kao Corp | Fat or oil composition |
FR2569561B1 (en) * | 1984-08-30 | 1990-05-18 | Oreal | STABLE ANTHRALIN COMPOSITION IN SATURATED FATTY ACID TRIGLYCERIDES OF PLANT ORIGIN WITH 6 TO 12 CARBON ATOMS |
JP2537658B2 (en) * | 1987-04-13 | 1996-09-25 | 小野薬品工業株式会社 | Novel formulation containing ester or amide as active ingredient |
IL87219A0 (en) * | 1987-08-07 | 1988-12-30 | Abbott Lab | Erythromycin formulations for oral administration |
JP5666760B2 (en) * | 2005-03-31 | 2015-02-12 | サントリーホールディングス株式会社 | Composition containing lignan compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE567598A (en) * |
-
1972
- 1972-11-18 JP JP11602172A patent/JPS4971127A/ja active Pending
-
1973
- 1973-11-13 GB GB5273473A patent/GB1432784A/en not_active Expired
- 1973-11-14 BE BE137740A patent/BE807312A/en not_active IP Right Cessation
- 1973-11-16 FR FR7340923A patent/FR2206943B1/fr not_active Expired
- 1973-11-16 DE DE19732357389 patent/DE2357389A1/en not_active Withdrawn
- 1973-11-19 CA CA186,200A patent/CA1036072A/en not_active Expired
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4202888A (en) * | 1976-07-12 | 1980-05-13 | Kali-Chemie Pharma Gmbh. | Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof |
US4263313A (en) | 1977-02-24 | 1981-04-21 | Kali-Chemie Pharma Gmbh | Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof |
US4230702A (en) * | 1978-01-09 | 1980-10-28 | Kali-Chemie Pharma Gmbh | Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents |
US4722941A (en) * | 1978-06-07 | 1988-02-02 | Kali-Chemie Pharma Gmbh | Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof |
US5156842A (en) * | 1987-06-19 | 1992-10-20 | Elan Corporation, Plc | Liquid suspension for oral administration |
US7943663B2 (en) | 2005-09-30 | 2011-05-17 | Suntory Holdings Limited | Process and an apparatus for producing episesamin-rich compositions |
US9408803B2 (en) | 2006-03-31 | 2016-08-09 | Suntory Holdings Limited | Compositions containing lignan-class compounds |
Also Published As
Publication number | Publication date |
---|---|
DE2357389A1 (en) | 1974-05-22 |
CA1036072A (en) | 1978-08-08 |
AU6254373A (en) | 1975-05-15 |
BE807312A (en) | 1974-03-01 |
FR2206943B1 (en) | 1977-09-02 |
JPS4971127A (en) | 1974-07-10 |
FR2206943A1 (en) | 1974-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1432784A (en) | Orally administrable pharmaceutical compositions | |
CA2132012A1 (en) | Alkyl-substituted cellulose-based sustained-release oral drug dosage forms | |
DK128283A (en) | PHARMACEUTICAL PREPARATIONS TO BE ADMINISTRATED ORAL | |
ES2097155T3 (en) | EFFERVESCENT DOSAGE FORM AND METHOD OF ADMINISTRATION. | |
RU94032150A (en) | Medicinal agent exhibiting delayed release of active-acting substance | |
IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
KR880010758A (en) | Sustained release preparations | |
BE900605A (en) | PHARMACEUTICAL COMPOSITIONS WITH ANTI-INFLAMMATORY AND / OR ANALGESIC ACTIVITY, NON ULCEROGENIC. | |
DE3573884D1 (en) | Substained release tablets and method for preparation thereof | |
MC1969A1 (en) | METHODS FOR PREPARING ANTI-TUMOR COMPOUNDS, PHARMACEUTICAL FORMULATION CONTAINING THE SAME, USE THEREOF IN MEDICINE AND PHARMACY, AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARATION | |
DK0421541T3 (en) | Shared tablet structure | |
WO2000025756A3 (en) | Medicament for topical treatment of inflammatory intestinal diseases | |
ES531346A0 (en) | PROCEDURE TO PRODUCE AN ORAL ADMINISTRATION TABLET OF CONTROLLED LIBERATION, INDEPENDENT OF THE PH | |
EP0271151A3 (en) | Azumolene dosage form | |
IE35419B1 (en) | Muscle-relaxant compositions | |
IE33949B1 (en) | Compositions for treating gastrointestinal disorders | |
AU474505B2 (en) | Pharmaceutical composition containing 2-hydroxy-methyl-3-phenyl-4(3h)-quinazolinone or pharmaceutically acceptable acid salts thereof and method of treatment | |
IE35711L (en) | Pharmaceutical compositions | |
Ota et al. | A double-blind comparison of haloperidol oral concentrate, haloperidol solutabs and placebo in the treatment of chronic schizophrenia. | |
MY129255A (en) | A new physical form of artemisinin and its use in the production of pharmaceuticals | |
RU2173999C2 (en) | Nonnarcotic analgetic and antipyretic drug and method of its preparing | |
Levy | Pharmacy: Hospital Pharmacists' New Frontiers | |
KR790000319B1 (en) | Process of manufacturing 2,4-diamino-pyrimidine with a sulphonamide | |
GB1454390A (en) | Nasal decongestants | |
NL154419B (en) | PROCESS FOR THE PREPARATION OF MEDICINAL PRODUCTS CONTAINING (BETA-PHENYLSULFINYLETHYL) -N, N'-DIPHENYL-MALONIC ACID MONOHYDRAZIDE AND / OR ONE OR MORE PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |